ENKAM PHARMACEUTICALS ApS: Financial statements 2015
CVR: 25812921
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -425,840 and a net result of DKK -488,005 compared with DKK 2,812,225 the year before. Equity in the 2015 report amounted to DKK -263,400.
- Gross Profit
- DKK -425,840
- Profit/Loss
- DKK -488,005
- Equity
- DKK -263,400
- Total Assets
- DKK 526,461
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -426 t. | -488 t. | -263 t. | - |
| 2014 | - | 4.7 mio. | 2.8 mio. | -1.9 mio. | - |
| 2013 | - | -2.6 mio. | -3.7 mio. | -4.7 mio. | - |
| 2012 | - | -1.1 mio. | -2.5 mio. | -3.5 mio. | - |
Official annual report
How creditworthy is ENKAM PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ENKAM PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 4,669,049, and the net result was DKK 2,812,225.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.